DSM and Taiyo Announce Licensing Agreement

DSM and Taiyo Kagaku Co Ltd (Taiyo) have entered into a licensing deal, effective July 1, 2014, which will transfer the entirety of the Teavigo brand EGCG business to Taiyo, the company announced.

Under terms of the deal, Taiyo will become the sole producer of Teavigo^® by the end of 2014.

Teavigo^® brand EGCG had previously been distributed under license by Pharmachem Laboratories, Inc. (Pharmachem) in the Dietary Supplement segment and by DSM in the Food and Beverage segments. Taiyo will now take responsibility for all customer segments, globally.

“DSM appreciates its historical relationship with Pharmachem on Teavigo^® and the great job they did in the Dietary Supplement segment,” said Will Black, VP Marketing, and DSM Nutritional Products.

He added, “We are delighted that Taiyo have taken over the Teavigo^® business. Taiyo’s solid reputation, extensive product portfolio, knowledge of the market and global reach make them a perfect fit for the Teavigo^® business.”

During the transitional period, DSM, Pharmachem and Taiyo, will collectively work together to allow for an orderly transition for all Teavigo® customers and are dedicated to assure an uninterrupted supply of Teavigo® EGCG.

Taiyo is a manufacturer of functional ingredients for the food, beverage and supplement industries. The company focuses on the development of innovative ingredients, derived from natural sources, to further develop the body’s ability to protect and manage one’s health.